Correlation Between Pfizer and Fidelity Blue

Can any of the company-specific risk be diversified away by investing in both Pfizer and Fidelity Blue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Fidelity Blue into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Fidelity Blue Chip, you can compare the effects of market volatilities on Pfizer and Fidelity Blue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Fidelity Blue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Fidelity Blue.

Diversification Opportunities for Pfizer and Fidelity Blue

-0.67

Correlation Coefficient

Pfizer  Fidelity Blue

Excellent diversification

The 3 months correlation between Pfizer and Fidelity is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Fidelity Blue Chip in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Blue Chip and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Fidelity Blue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Blue Chip has no effect on the direction of Pfizer i.e., Pfizer and Fidelity Blue go up and down completely randomly.

Pair Corralation between Pfizer and Fidelity Blue

Considering the 90-day investment horizon Pfizer Inc is expected to generate 2.37 times more return on investment than Fidelity Blue. However, Pfizer is 2.37 times more volatile than Fidelity Blue Chip. It trades about 0.12 of its potential returns per unit of risk. Fidelity Blue Chip is currently generating about -0.11 per unit of risk. If you would invest  2,480  in Pfizer Inc on September 16, 2024 and sell it today you would earn a total of  78.00  from holding Pfizer Inc or generate 3.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Fidelity Blue Chip

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Fidelity Blue Chip

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Blue Chip are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable fundamental indicators, Fidelity Blue is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Pfizer and Fidelity Blue

The main advantage of trading using opposite Pfizer and Fidelity Blue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Fidelity Blue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Blue will offset losses from the drop in Fidelity Blue's long position.

The idea behind Pfizer Inc and Fidelity Blue Chip pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.